These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 14675406

  • 1. Successful treatment without cranial radiotherapy of children receiving intensified chemotherapy for acute lymphoblastic leukaemia: results of the risk-stratified randomized central nervous system treatment trial MRC UKALL XI (ISRC TN 16757172).
    Hill FG, Richards S, Gibson B, Hann I, Lilleyman J, Kinsey S, Mitchell C, Harrison CJ, Eden OB, UK Medical Research Council Working Party on Childhood Leukaemia.
    Br J Haematol; 2004 Jan; 124(1):33-46. PubMed ID: 14675406
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Medical Research Council Working Party on Childhood Leukaemia.
    Chessells JM, Bailey C, Richards SM.
    Lancet; 1995 Jan 21; 345(8943):143-8. PubMed ID: 7823668
    [Abstract] [Full Text] [Related]

  • 5. CNS-directed therapy for childhood acute lymphoblastic leukemia: Childhood ALL Collaborative Group overview of 43 randomized trials.
    Clarke M, Gaynon P, Hann I, Harrison G, Masera G, Peto R, Richards S, Childhood ALL Collaborative Group.
    J Clin Oncol; 2003 May 01; 21(9):1798-809. PubMed ID: 12721257
    [Abstract] [Full Text] [Related]

  • 6. Effective preventive central nervous system therapy with extended triple intrathecal therapy and the modified ALL-BFM 86 chemotherapy program in an enlarged non-high risk group of children and adolescents with non-B-cell acute lymphoblastic leukemia: the Israel National Study report.
    Stark B, Sharon R, Rechavi G, Attias D, Ballin A, Cividalli G, Burstein Y, Sthoeger D, Abramov A, Zaizov R.
    Cancer; 2000 Jan 01; 88(1):205-16. PubMed ID: 10618625
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Benefit of intensified treatment for all children with acute lymphoblastic leukaemia: results from MRC UKALL XI and MRC ALL97 randomised trials. UK Medical Research Council's Working Party on Childhood Leukaemia.
    Hann I, Vora A, Richards S, Hill F, Gibson B, Lilleyman J, Kinsey S, Mitchell C, Eden OB.
    Leukemia; 2000 Mar 01; 14(3):356-63. PubMed ID: 10720126
    [Abstract] [Full Text] [Related]

  • 10. Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana di Ematologia ed Oncologia Pediatrica.
    Conter V, Aricò M, Valsecchi MG, Rizzari C, Testi AM, Messina C, Mori PG, Miniero R, Colella R, Basso G.
    J Clin Oncol; 1995 Oct 01; 13(10):2497-502. PubMed ID: 7595699
    [Abstract] [Full Text] [Related]

  • 11. Prevention of CNS recurrence in childhood ALL: results with reduced radiotherapy combined with CNS-directed chemotherapy in four consecutive ALL-BFM trials.
    Schrappe M, Reiter A, Henze G, Niemeyer C, Bode U, Kühl J, Gadner H, Havers W, Plüss H, Kornhuber B, Zintl F, Ritter J, Urban C, Niethammer D, Riehm H.
    Klin Padiatr; 1998 Oct 01; 210(4):192-9. PubMed ID: 9743952
    [Abstract] [Full Text] [Related]

  • 12. Hypofractionated moderate dose radiation, intrathecal chemotherapy, and repetitive reinduction/reconsolidation systemic therapy for central nervous system relapse of acute lymphoblastic leukemia in children.
    Belasco JB, Goldwein JW, Simms S, Griffin G, D'Angio G, Lange B.
    Med Pediatr Oncol; 2000 Feb 01; 34(2):125-31. PubMed ID: 10657874
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Methotrexate infusions as central nervous system prophylaxis in children with acute lymphocytic leukemia: the Norwegian experience.
    Moe PJ, Holen A, Nygaard R, Glomstein A, Madsen B, Hellebostad M, Stokland T, Wefring KW, Steen-Johnsen J, Nielsen B, Hapnes C, Børsting S.
    Pediatr Hematol Oncol; 2003 Feb 01; 20(3):187-200. PubMed ID: 12637215
    [Abstract] [Full Text] [Related]

  • 15. Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: results of the Children's Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic leukemia, reported by the Children's Oncology Group.
    Matloub Y, Lindemulder S, Gaynon PS, Sather H, La M, Broxson E, Yanofsky R, Hutchinson R, Heerema NA, Nachman J, Blake M, Wells LM, Sorrell AD, Masterson M, Kelleher JF, Stork LC, Children's Oncology Group.
    Blood; 2006 Aug 15; 108(4):1165-73. PubMed ID: 16609069
    [Abstract] [Full Text] [Related]

  • 16. An intensive re-treatment protocol for children with an isolated CNS relapse of acute lymphoblastic leukemia.
    Ribeiro RC, Rivera GK, Hudson M, Mulhern RK, Hancock ML, Kun L, Mahmoud H, Sandlund JT, Crist WM, Pui CH.
    J Clin Oncol; 1995 Feb 15; 13(2):333-8. PubMed ID: 7844594
    [Abstract] [Full Text] [Related]

  • 17. Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol.
    Hann I, Vora A, Harrison G, Harrison C, Eden O, Hill F, Gibson B, Richards S, UK Medical Research Council's Working Party on Childhood Leukaemia.
    Br J Haematol; 2001 Apr 15; 113(1):103-14. PubMed ID: 11328289
    [Abstract] [Full Text] [Related]

  • 18. The impact of therapy for childhood acute lymphoblastic leukaemia on intelligence quotients; results of the risk-stratified randomized central nervous system treatment trial MRC UKALL XI.
    Halsey C, Buck G, Richards S, Vargha-Khadem F, Hill F, Gibson B.
    J Hematol Oncol; 2011 Oct 13; 4():42. PubMed ID: 21996369
    [Abstract] [Full Text] [Related]

  • 19. Role of cranial radiotherapy for childhood T-cell acute lymphoblastic leukemia with high WBC count and good response to prednisone. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Münster groups.
    Conter V, Schrappe M, Aricó M, Reiter A, Rizzari C, Dördelmann M, Valsecchi MG, Zimmermann M, Ludwig WD, Basso G, Masera G, Riehm H.
    J Clin Oncol; 1997 Aug 13; 15(8):2786-91. PubMed ID: 9256120
    [Abstract] [Full Text] [Related]

  • 20. CNS-directed therapy in young children with T-lineage acute lymphoblastic leukemia: High-dose methotrexate versus cranial irradiation.
    Nathan PC, Maze R, Spiegler B, Greenberg ML, Weitzman S, Hitzler JK.
    Pediatr Blood Cancer; 2004 Jan 13; 42(1):24-9. PubMed ID: 14752790
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.